Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)

Pekka Nuorti

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)

Pekka Nuorti

Tutkimustuotos: Katsausartikkeli › vertaisarvioitu

451 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	1-18
Julkaisu	Morbidity and Mortality Weekly Report
Vuosikerta	59
Numero	RR11
Tila	Julkaistu - 2010
Julkaistu ulkoisesti	Kyllä
OKM-julkaisutyyppi	A2 Katsausartikkeli tieteellisessä aikakauslehdessä

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Pääsy asiakirjaan

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm

Siteeraa tätä

@article{089502b5c19940009afe4ff99de500ef,

title = "Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)",

author = "Pekka Nuorti",

year = "2010",

language = "English",

volume = "59",

pages = "1--18",

journal = "Morbidity and Mortality Weekly Report",

issn = "0149-2195",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "RR11",

}

Nuorti, P 2010, 'Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)', Morbidity and Mortality Weekly Report, Vuosikerta 59, Nro RR11, Sivut 1-18. <http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm>

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). / Nuorti, Pekka.
julkaisussa: Morbidity and Mortality Weekly Report, Vuosikerta 59, Nro RR11, 2010, s. 1-18.

Tutkimustuotos: Katsausartikkeli › vertaisarvioitu

TY - JOUR

T1 - Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)

AU - Nuorti, Pekka

PY - 2010

Y1 - 2010

M3 - Review Article

SN - 0149-2195

VL - 59

SP - 1

EP - 18

JO - Morbidity and Mortality Weekly Report

JF - Morbidity and Mortality Weekly Report

IS - RR11

ER -